Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T KOSUGE

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Lancet (London, England)|November 10, 1990
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinomaT Takayama, M Makuuchi, S Hirohashi, et al.
Journal of Gastroenterology and Hepatology|July 1, 1991
Growing cavernous haemangioma of the liver: 11-fold increase in volume in a decadeJ Yoshida, S Yamasaki, J Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1992
[Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer]N Ohwada, M Nagayama, T Kosuge, et al.
Japanese Journal of Clinical Oncology|April 1, 1993
Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosisT Fujii, K Takayasu, Y Muramatsu, et al.
Cancer Letters|July 29, 1999
A novel splicing mutation (894-9 G --> A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1M Kishi, T Tsukada, S Shimizu, et al.
Surgery|June 1, 1992
Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five yearsJ Yamamoto, T Kosuge, T Takayama, et al.
Cancer|May 1, 1996
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injectionH Ishii, S Okada, H Nose, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Early hepatocellular carcinoma as an entity with a high rate of surgical cureT Takayama, M Makuuchi, S Hirohashi, et al.
British Journal of Cancer|June 16, 2011
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinomaM Miyamoto, H Ojima, M Iwasaki, et al.
Lancet (London, England)|October 7, 2000
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trialT Takayama, T Sekine, M Makuuchi, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|November 10, 1990
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinomaT Takayama, M Makuuchi, S Hirohashi, et al.
Journal of Gastroenterology and Hepatology|July 1, 1991
Growing cavernous haemangioma of the liver: 11-fold increase in volume in a decadeJ Yoshida, S Yamasaki, J Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1992
[Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer]N Ohwada, M Nagayama, T Kosuge, et al.
Japanese Journal of Clinical Oncology|April 1, 1993
Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosisT Fujii, K Takayasu, Y Muramatsu, et al.
Cancer Letters|July 29, 1999
A novel splicing mutation (894-9 G --> A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1M Kishi, T Tsukada, S Shimizu, et al.
Surgery|June 1, 1992
Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five yearsJ Yamamoto, T Kosuge, T Takayama, et al.
Cancer|May 1, 1996
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injectionH Ishii, S Okada, H Nose, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Early hepatocellular carcinoma as an entity with a high rate of surgical cureT Takayama, M Makuuchi, S Hirohashi, et al.
British Journal of Cancer|June 16, 2011
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinomaM Miyamoto, H Ojima, M Iwasaki, et al.
Lancet (London, England)|October 7, 2000
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trialT Takayama, T Sekine, M Makuuchi, et al.
Pageof 22